EUROPEAN ACADEMY OF
ALLERGY & CLINICAL IMMUNOLOGY

DEDICATED TO ALLERGY SCIENCE,
COMMITED TO YOUR HEALTH

Introduction to the Infection & Allergy IG

Infection_and_allergy_picFrom the EAACI Bylaws

In order to allow EAACI to influence and keep updated information on matters related to allergy and clinical immunology, it has been decided to create “Interest Groups”. An Interest Group represents an area of general interest within allergology that is not well covered by any one of the EAACI Sections.

The Infections & Allergy IG is officially sanctioned and fully active. The Interest Group on Infection & Allergy aims at raising the interest of clinicians and scientists in the interrelation between infection and allergy. An association between the two dates back to the beginnings of allergy, immunology and microbiology. Investigations which focused on the pathogenesis of bacterial infections led to the discovery of the human immune system and the concept of allergy.

Currently covered topics include: infections (viral, parasitic, fungal,
superantigen-related) as an aggravating factor of pre-existing allergic disease or an inducer of allergy de novo; infections as a protective modifier of allergy development (hygiene hypothesis); allergy to vaccines; vaccinations as possible modifiers of allergy development; the use of antivirals, antibiotics, antifungals, pre-and pro-biotics for the prevention and/or treatment of allergic disorders.


Board 2013-2015

Chairperson
Chrysanthi Skevaki
Greece
This email address is being protected from spambots. You need JavaScript enabled to view it.

Secretary
Hermelijn Smits
Netherlands
This email address is being protected from spambots. You need JavaScript enabled to view it.
This email address is being protected from spambots. You need JavaScript enabled to view it.">

Members

Thai Dinh
Germany
This email address is being protected from spambots. You need JavaScript enabled to view it.

Michael Edwards
United Kingdom
This email address is being protected from spambots. You need JavaScript enabled to view it.

Tuomas Jartti
Finland
This email address is being protected from spambots. You need JavaScript enabled to view it.

Maria Yazdanbakhsh
Netherlands
This email address is being protected from spambots. You need JavaScript enabled to view it.

Nan Zhang
Belgium
This email address is being protected from spambots. You need JavaScript enabled to view it.

 

Last updated 07 August 2013